Literature DB >> 7591285

Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma.

H Kawamata1, K Kawai, S Kameyama, M D Johnson, W G Stetler-Stevenson, R Oyasu.   

Abstract

The balance between matrix metalloproteinases and their inhibitors is a critical factor which affects tumor invasion and metastasis. We have established a rat bladder carcinoma cell line, LMC19, which is tumorigenic, invasive and metastatic to the retroperitoneal lymph nodes and to the lungs in nude mice. LMC19 cells secrete pro-gelatinases A and B as well as tissue inhibitors of matrix metalloproteinase (TIMP1 and TIMP2). We conducted the present study to determine whether or not over-expression of TIMP1 and TIMP2 can affect the metastatic potential of LMC19 cells. We transfected the cells with an expression vector containing TIMP1 or TIMP2 cDNA, isolated several clones over-expressing TIMP1 or TIMP2 and assessed their invasive and metastatic potential by inoculation at an orthotopic site (urinary bladder) in nude mice. Our results show that the transfectants over-expressing TIMP1 and TIMP2 marginally affect primary tumor growth, local invasion or metastasis to the retroperitoneal lymph nodes but significantly inhibit extravascular growth of pulmonary tumor emboli. Our results suggest that the net activity of matrix metalloproteinases of tumor cells may be a critical factor that controls extravasation at this distant metastatic site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591285     DOI: 10.1002/ijc.2910630513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

Review 1.  A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.

Authors:  L Yan; M A Moses
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 3.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

4.  The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action.

Authors:  Chih-Min Yang; Yi-Zih Liu; Jiunn-Wang Liao; Miao-Lin Hu
Journal:  Clin Exp Metastasis       Date:  2010-05-07       Impact factor: 5.150

Review 5.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

6.  Differential functional significance of AP-1 binding sites in the promoter of the gene encoding mouse tissue inhibitor of metalloproteinases-3.

Authors:  H Kim; W D Pennie; Y Sun; N H Colburn
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

7.  High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.

Authors:  N Kitamura; T Iwamura; S Taniguchi; H Yamanari; M A Kawano; K Hollingsworth; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colonization in lung adenocarcinoma.

Authors:  Ying-Hua Chang; Yi-Jen Chiu; Hung-Chi Cheng; Fang-Ju Liu; Wu-Wei Lai; Hsiao-Jen Chang; Pao-Chi Liao
Journal:  Tumour Biol       Date:  2015-01-13

9.  The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model.

Authors:  A Boussommier-Calleja; Y Atiyas; K Haase; M Headley; C Lewis; R D Kamm
Journal:  Biomaterials       Date:  2018-03-05       Impact factor: 12.479

10.  MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2.

Authors:  Odete Mendes; Hun-Taek Kim; Gina Lungu; George Stoica
Journal:  Clin Exp Metastasis       Date:  2007-05-16       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.